ClinicalTrials.govpublic full text
Multi-Centre, Prospective, Non-Interventional Study to Intensively Monitor the Safety of Sintilimab in Clinical Practice Among Chinese Patients
immune related adverse events, pd-1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 141002
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.